Missing the first mammogram linked to increased risk of breast cancer death, new study suggests

Women who miss their first screening appointment for breast cancer could have a 40% higher long-term risk of dying from the ...
Cancer Therapy Advisor

Collaborative Quality Improvement Initiative Cuts Radiotherapy No-Show Rates

A collaborative quality improvement initiative involving ACS-accredited radiotherapy programs sought to improve no show rates in patients with cancer.

I Couldn’t Sleep For Months—Until I Tried This Violent Pain Treatment

Do you want a towel to bite down on?” my physical therapist asked. I trusted her, but I knew this was going to hurt.
Hosted on MSN

Mayor-elect Zoran Mamdani unveils first key appointments at City Hall

Fuleihan brings decades of government experience from City Hall to Albany, while Bisgard Church, a Democratic Socialist, has been instrumental in Mamdani’s political rise. Despite early pushback from ...
WRIC

Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer

HONG KONG, Nov. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for ...
Enid News & Eagle

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer

The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU ® (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed ...